Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 253

1.

Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast cancer.

Page DL, Dupont WD, Jensen RA.

Cancer Epidemiol Biomarkers Prev. 1996 Jan;5(1):29-32.

2.

Indicators of increased breast cancer risk in humans.

Page DL, Dupont WD.

J Cell Biochem Suppl. 1992;16G:175-82. Review.

PMID:
1469898
3.

Breast cancer risk associated with proliferative breast disease and atypical hyperplasia.

Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, Schuyler PA, Plummer WD.

Cancer. 1993 Feb 15;71(4):1258-65. Review.

PMID:
8435803
4.

Invasive breast cancer risk in women with sclerosing adenosis.

Jensen RA, Page DL, Dupont WD, Rogers LW.

Cancer. 1989 Nov 15;64(10):1977-83.

PMID:
2804888
5.

Prognostic significance of benign proliferative breast disease.

Bodian CA, Perzin KH, Lattes R, Hoffmann P, Abernathy TG.

Cancer. 1993 Jun 15;71(12):3896-907.

PMID:
8389654
6.
7.

Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.

Marshall LM, Hunter DJ, Connolly JL, Schnitt SJ, Byrne C, London SJ, Colditz GA.

Cancer Epidemiol Biomarkers Prev. 1997 May;6(5):297-301.

8.

Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up.

Seidman JD, Ashton M, Lefkowitz M.

Cancer. 1996 Jun 15;77(12):2529-37.

PMID:
8640702
9.

Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study.

Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ.

Cancer. 2007 Jan 15;109(2):180-7.

10.

Radial scars in benign breast-biopsy specimens and the risk of breast cancer.

Jacobs TW, Byrne C, Colditz G, Connolly JL, Schnitt SJ.

N Engl J Med. 1999 Feb 11;340(6):430-6.

11.

Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma.

Page DL, Salhany KE, Jensen RA, Dupont WD.

Cancer. 1996 Jul 15;78(2):258-66.

PMID:
8674001
12.

A prospective study of the development of breast cancer in 16,692 women with benign breast disease.

Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR.

Am J Epidemiol. 1988 Sep;128(3):467-77.

PMID:
3414655
13.

Risk factors for breast cancer in women with proliferative breast disease.

Dupont WD, Page DL.

N Engl J Med. 1985 Jan 17;312(3):146-51.

PMID:
3965932
14.
15.

Benign breast disease and the risk of breast cancer.

Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJ 3rd, Visscher DW.

N Engl J Med. 2005 Jul 21;353(3):229-37.

16.
17.

Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies.

Sanders ME, Page DL, Simpson JF, Schuyler PA, Dale Plummer W, Dupont WD.

Cancer. 2006 Apr 1;106(7):1453-61.

18.

Breast cancer risk of lobular-based hyperplasia after biopsy: "ductal" pattern lesions.

Page DL, Dupont WD, Rogers LW.

Cancer Detect Prev. 1986;9(5-6):441-8.

PMID:
3779706
19.

Clinicopathologic analysis of breast lesions associated with multiple papillomas.

Ali-Fehmi R, Carolin K, Wallis T, Visscher DW.

Hum Pathol. 2003 Mar;34(3):234-9.

PMID:
12673557
20.

Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?

Middleton LP, Grant S, Stephens T, Stelling CB, Sneige N, Sahin AA.

Mod Pathol. 2003 Feb;16(2):120-9.

Supplemental Content

Support Center